| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,054 |
7,887 |
$651K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,033 |
2,692 |
$241K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,511 |
1,404 |
$149K |
| 87428 |
|
1,496 |
1,413 |
$45K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,717 |
1,477 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,421 |
3,145 |
$24K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
56 |
55 |
$8K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
51 |
45 |
$6K |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
10,020 |
8,558 |
$2K |
| 81002 |
|
1,256 |
1,136 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
222 |
112 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
373 |
261 |
$964.44 |
| 80053 |
Comprehensive metabolic panel |
204 |
186 |
$793.53 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
46 |
44 |
$554.90 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
313 |
275 |
$313.32 |
| 87807 |
|
188 |
171 |
$268.64 |
| 71046 |
Radiologic examination, chest; 2 views |
86 |
80 |
$147.11 |
| 36415 |
Collection of venous blood by venipuncture |
192 |
184 |
$42.05 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
104 |
57 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
17 |
16 |
$0.00 |